Government grants are available for Australian businesses in the biomedical sector. Programs span federal and state governments, offering funding for growth, innovation, infrastructure and workforce development.
What these grants can fund
- Business expansion and capital investment
- Equipment and infrastructure upgrades
- Workforce training and skills development
- Technology adoption and innovation
- Export and market development
Common eligibility requirements
- Registered Australian business with a valid ABN
- Must be operating in the relevant sector
- Matching co-contribution may be required
- Some programs have employee or turnover thresholds
Eligibility varies by program. Always check the official source before applying.
Open programs
Showing 4 of 4The Private Sector Pathways Program supports Queensland-based small-to-medium enterprises to collaborate with corporate partners on solving specific business challenges and developing commercialisation opportunities. Selected applicants receive co-funding of up to $200,000 from the Queensland government and their corporate partner to trial innovative solutions over 6-12 months, while retaining intellectual property ownership.
An equity co-investment venture capital program that provides early-stage biomedical companies with investment to develop and commercialise biomedical discoveries. The fund supports therapeutic, medical, pharmaceutical products, processes, services, technologies and procedures that improve health and wellbeing through prevention, diagnosis and treatment.
The Biomedical Translation Fund provides capital to support groundbreaking innovation in Australia, helping commercialize research from universities and research organizations into commercial products. The fund pools $500 million in total capital ($250 million from the federal government and $250 million from private investors) to support venture capital managers in taking Australian biomedical innovations through the commercial pathway.
A venture capital program that provides capital and professional expertise to innovative Australian early-stage companies and high-growth startups. The program offers increased fund sizes up to $200 million, a 10% tax offset on capital deployed into start-up companies, and a tax-exempt environment for investment returns.
Grant information is sourced from official government websites and updated regularly. Program details, eligibility and closing dates change — always verify with the official source before applying. Last data update: February 2026.